Published in Brain Res on October 08, 1990
Dopamine in motivational control: rewarding, aversive, and alerting. Neuron (2010) 6.26
The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states. Brain Res Bull (2008) 1.43
Encoding of aversion by dopamine and the nucleus accumbens. Front Neurosci (2012) 1.13
Pains in Parkinson disease--many syndromes under one umbrella. Nat Rev Neurol (2012) 1.01
The role of dopamine in the context of aversive stimuli with particular reference to acoustically signaled avoidance learning. Front Neurosci (2012) 0.97
The parabrachial nucleus is a critical link in the transmission of short latency nociceptive information to midbrain dopaminergic neurons. Neuroscience (2010) 0.93
Lesions of the fasciculus retroflexus alter footshock-induced cFos expression in the mesopontine rostromedial tegmental area of rats. PLoS One (2013) 0.90
The striatum and pain modulation. Cell Mol Neurobiol (2011) 0.81
Habenula-Induced Inhibition of Midbrain Dopamine Neurons Is Diminished by Lesions of the Rostromedial Tegmental Nucleus. J Neurosci (2017) 0.76
Functional evidence for a direct excitatory projection from the lateral habenula to the ventral tegmental area in the rat. J Neurophysiol (2016) 0.75
Association between habenula dysfunction and motivational symptoms in unmedicated major depressive disorder. Soc Cogn Affect Neurosci (2017) 0.75
Tonic or phasic stimulation of dopaminergic projections to prefrontal cortex causes mice to maintain or deviate from previously learned behavioral strategies. J Neurosci (2017) 0.75
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology (2002) 1.89
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56
Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol (1997) 1.48
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord (1998) 1.47
Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43
Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42
Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41
[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28
Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet (1979) 1.27
Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J (1992) 1.24
Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain (2003) 1.23
Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) (1993) 1.18
Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17
Subcutaneous apomorphine in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 1.16
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology (2000) 1.16
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Subthalamic nucleus, sensorimotor cortex and muscle interrelationships in Parkinson's disease. Brain (2001) 1.13
Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry (2007) 1.12
EGF receptor amplification and expression in human brain tumours. Eur J Cancer (1992) 1.12
Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain (2001) 1.11
Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry (2007) 1.11
Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) (1995) 1.11
Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol (1989) 1.09
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord (1996) 1.08
Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang (2001) 1.08
Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism. J Neurol Neurosurg Psychiatry (1999) 1.07
Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma. Neuroradiology (2004) 1.06
Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet (1997) 1.05
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.05
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol (2001) 1.05
From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain (1999) 1.05
Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. Brain Res (2001) 1.05
Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci (1996) 1.04
Subthalamic stimulation for Parkinson's disease. Arch Med Res (2000) 1.04
Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet (1997) 1.03
Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain (1993) 1.03
Functional MRI of the human brain: predominance of signals from extracerebral veins. Neuroreport (1994) 1.01
Encephalopathy, deafness and blindness in young women: a distinct retinocochleocerebral arteriolopathy? J Neurol Neurosurg Psychiatry (1989) 1.01
Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp Neurol (2006) 1.00
Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease. J Neurol (1999) 0.98
Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology (2002) 0.98
Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci (2000) 0.98
[Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease]. Rev Neurol (Paris) (1990) 0.98
Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience (2008) 0.98
Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia. J Neurol Neurosurg Psychiatry (1987) 0.97
Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology (2000) 0.97
Simultaneous recording of spontaneous activities and nociceptive responses from neurons in the pars compacta of substantia nigra and in the lateral habenula. Eur J Neurosci (1996) 0.96